The sensitivity of gram-negative and gram-positive bacteria to ofloxacin. 1987

A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
Institute of Microbiology, University of Catania, Italy.

The in vitro antimicrobial activity of ofloxacin, a new fluorinated quinolone, was evaluated against 165 Gram-negative rods, both fermentative and non-fermentative, and against 57 Gram-positive strains (coagulase-positive and -negative staphylococci both methicillin-resistant and -susceptible, and Streptococcus faecalis). Minimal inhibitory concentrations were determined by using the macrodilution test and the activity was compared with nalidixic acid, norfloxacin, ampicillin, piperacillin, ceftazidime and gentamicin for Gram-negative rods; norfloxacin and gentamicin for Staphylococcus strains; and norfloxacin, ampicillin, piperacillin and gentamicin for enterococci. Ofloxacin inhibited all fermentative Gram-negative bacteria tested, in a range of 0.05-3.12 mcg/ml, and had good antimicrobial activity against non-fermentative Gram-negative strains: it inhibited 90% of Acinetobacter and 80% of P. aeruginosa tested, at 3.12 mcg/ml. Ofloxacin had a high antimicrobial activity against Staphylococcus and Enterococcus strains tested.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
February 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
December 2016, Scientific reports,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
January 1988, Mikrobiyoloji bulteni,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
December 1978, Helvetica chirurgica acta,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
January 1998, Chemotherapy,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
April 1991, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
August 1997, Current microbiology,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
January 1987, Drugs under experimental and clinical research,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
February 2014, FEMS microbiology letters,
A Speciale, and S Stefani, and F Caccamo, and V M Nicolosi, and G Nicoletti
March 1973, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!